2016 PREVIEW: China - Three Regulatory Trends To Watch
This article was originally published in PharmAsia News
The year of 2015 in the China pharma market was marked by a drastic market slowdown and turbulent regulatory headwinds. But looking ahead, analysts say that while many challenges remain, some important breakthroughs could be on the way.
Register for our free email digests: